Staurosporine emerges as a potent kinase inhibitor, capable of arresting numerous protein kinases that are pivotal in signal transduction. Its broad-spectrum activity allows it to impede a multitude of pathways, potentially including those that the protein LOC642861 might influence. LY294002 and Wortmannin are both specific inhibitors of PI3K, a key enzyme in the PI3K/Akt pathway, which is instrumental in governing cell survival, growth, and metabolism. Their inhibition of PI3K can exert a substantial downregulation of this signaling cascade, thereby influencing proteins involved in these routes. Rapamycin acts on the mTOR pathway, a central conduit for cell growth and proliferation signals, by specifically binding to mTOR and impeding its activity.
Cycloheximide takes a different approach by targeting protein synthesis at the translational level, thereby affecting the protein turnover, which could indirectly influence the stability and expression levels of a range of proteins, including LOC642861 if it were to be involved in such cellular processes. Similarly, Bortezomib disrupts proteasomal degradation, a critical process for maintaining protein homeostasis, which can have cascading effects on cell cycle regulation and apoptosis.
The MEK inhibitors PD98059 and U0126, as well as the p38 MAP kinase inhibitor SB203580, selectively block key enzymes within the MAPK/ERK pathway, a pathway known for its role in regulating cell division and differentiation. By inhibiting these kinases, they can alter the phosphorylation state and activity of numerous downstream proteins. SP600125 inhibits JNK, which influences a wide range of cellular activities including proliferation, differentiation, and apoptosis, indicating that its effects can permeate through multiple layers of cellular regulation. Trichostatin A targets histone deacetylases, modifying chromatin dynamics and impacting gene expression patterns profoundly. Lastly, Z-VAD-FMK serves to impede apoptosis by binding to caspases, the proteases that execute cell death. Its inhibition of these proteases can lead to the prolongation of cell survival.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
A non-selective kinase inhibitor that can inhibit a broad spectrum of protein kinases and thus potentially affect multiple signaling pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A phosphoinositide 3-kinases (PI3K) inhibitor, which can disrupt PI3K/Akt signaling pathway, involved in cell survival and growth. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor that interferes with the mTOR signaling pathway, which is crucial for cell growth and proliferation. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Inhibits eukaryotic protein synthesis by interfering with the translocation step in protein synthesis, potentially affecting protein turnover. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
A specific inhibitor of mitogen-activated protein kinase kinase (MEK), affecting the MAPK/ERK pathway that regulates cell division and differentiation. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
Another MEK inhibitor that can block the MAPK/ERK signaling pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
A specific inhibitor of p38 MAP kinase, affecting inflammatory responses and cell differentiation. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of c-Jun N-terminal kinase (JNK), which influences cell proliferation, differentiation, and apoptosis. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Proteasome inhibitor, affecting the degradation of proteins involved in cell cycle regulation and apoptosis. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Histone deacetylase inhibitor, which can affect gene expression by altering chromatin structure and function. | ||||||